Symbiotec Pharmalab
₹14,820(15 Shares)
Minimum Investment
IPO Dates
Aug 24, 2026 – Aug 27, 2026
Price Band
₹938–988 per equity share
Issue Size
₹1757 Cr
Lot Size
15
Listing
Sep 1, 2026
Listing At
BSE, NSE
Unofficial pre-listing indicator
Symbiotec Pharmalab IPO GMP Today: ₹255
Symbiotec Pharmalab IPO GMP today is ₹255 per share (a 26% premium over the ₹988 upper price band) as of 28 Aug 2026, 04:52 PM IST. The indicative listing price is ₹1243 (₹988 upper price band + ₹255 GMP).
Current GMP
₹255
GMP percentage
26%
Upper price band
₹988
Indicative listing price
₹1243
GMP is informal, not exchange-published, and may change before listing. The indicative price is a calculation, not a forecast or an investment recommendation.
Symbiotec Pharmalab Live Subscription Details
All IPOsAll Live IPOsNII Sub-Categories
bHNI (> ₹10L)
Bids above ₹10L
sHNI (< ₹10L)
Bids ₹2L to ₹10L
Overall Subscription
Total Bids Received
75.06x
Symbiotec Pharmalab IPO Issue Details
- Issue Price
- ₹938-988 Per Equity Share
- Face Value
- ₹2 Per Equity Share
- Total Issue Size
- ₹1757 Cr
- Fresh Share
- 15,21,261 shares(aggregating up to ₹150 crore)
- Listing At
- BSE, NSE
- Listing Date
- Sep 1, 2026
- Lead Manager
- JM Financial Ltd., Motilal Oswal Investment Advisors Ltd., Avendus Capital Pvt.Ltd., Nomura Financial Advisory & Securities (India) Pvt.Ltd.
- Registrar
- MUFG Intime India Pvt.Ltd.
Market Lot Details
Reservation Details
Shares Offered
26,62,955
Shares Offered
35,50,608
Shares Offered
53,25,909
Company Information
Incorporated in 2002, Symbiotec Pharmalab Ltd. is a biopharmaceutical and bio technological company whose operations include development and manufacture of active pharmaceutical ingredients, nutrition...
Valuations
EPS (Pre-IPO)
17.82
EPS (Post-IPO)
17.39
P/E (Pre-IPO)
55.44
P/E (Post-IPO)
56.81
RoNW
9.48%
PAT Margin
12.60%
P/B Value
5.35
Market Cap
₹6,244.43 Cr.
Financial Information (₹ in Crores)
* All figures are in ₹ Crores unless otherwise stated.
Objectives of the Issue
- 1Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company
- 2General corporate purposes
Symbiotec Pharmalab – Promoter(s)
Contact Details
Corporate Office
385/2, Pigdamber, Rau, Mhow, Indore, Madhya Pradesh, 453331
Symbiotec Pharmalab Allotment & Registrar Details
Allotment HubMUFG Intime India Pvt.Ltd.
Symbiotec Pharmalab IPO Documents
Lead Managers
JM Financial Ltd.
Motilal Oswal Investment Advisors Ltd.
Avendus Capital Pvt.Ltd.
Nomura Financial Advisory & Securities (India) Pvt.Ltd.
Frequently Asked Questions — Symbiotec Pharmalab IPO
The Symbiotec Pharmalab IPO price band is set at ₹938.00 to ₹988.00 per equity share.
The total issue size of Symbiotec Pharmalab IPO is ₹1757 Cr.
The lot size for Symbiotec Pharmalab IPO is 15 shares per lot. The minimum investment amount is approximately ₹14,820.
The Symbiotec Pharmalab IPO opens on Aug 24, 2026 and closes on Aug 27, 2026.
The basis of allotment for Symbiotec Pharmalab IPO is expected to be finalized on Aug 28, 2026.
Symbiotec Pharmalab IPO is expected to be listed on Sep 1, 2026 on BSE, NSE.
The current GMP for Symbiotec Pharmalab IPO is ₹255, suggesting an expected listing price of around ₹1193.00. Note: GMP is an unofficial market indicator.
The registrar for Symbiotec Pharmalab IPO is MUFG Intime India Pvt.Ltd.. You can contact them at symbiotecpharmalab.ipo@in.mpms.mufg.com.
